Jeffrey Lieberman

Lieber Professor of Psychiatry · New York Presbyterian Hospital

Credentials: · ·

History

Human Trial of Allosteric Modulator Alpha7 Nicotinic Receptors in Schizophrenia
National Institute of Mental Health · U01
Contact PI · $1.1M · New York State Psychiatric Institute Dba Research Foundation for Mental Hygiene, Inc
2011–2018
Pharmacologic and Clinical Testing of a D1 Agonist for Neuropsychiatric Disorders
National Institute of Mental Health · U01
Contact PI · $2.1M · New York State Psychiatric Institute Dba Research Foundation for Mental Hygiene, Inc
2005–2014
Neurobiology of Dopamine in Schizophrenia
National Institute of Mental Health · P50
Contact PI · $8.3M · New York State Psychiatric Institute Dba Research Foundation for Mental Hygiene, Inc
2004–2010
Prospective Studies of the Pathogenesis of Schizophrenia
National Institute of Mental Health · P50
Contact PI · $3.6M · Univ of North Carolina Chapel Hill
2002–2007

ITI-007 (Lumateperone Tosylate) for Schizophrenia
Principal investigator · Terminated · Phase 2
New York State Psychiatric Institute
2019–2020
Effects of TS-134 on Ketamine-induced BOLD Signals in Healthy Subjects
Principal investigator · Completed · Phase 1
Taisho Pharmaceutical R&D Inc.
2017–2018
Clinical Trial of AVL-3288 in Schizophrenia Patients
Principal investigator · Completed · Phase 1
New York State Psychiatric Institute
2016–2018
Pomaglumetad Effects on Glutamate Biomarkers
Principal investigator · Completed · Phase 1
New York State Psychiatric Institute
2016–2018